Crohn's disease and Labyrinthitis

Summary:

Labyrinthitis is found among people with Crohn's disease, especially for people who are female, 60+ old.

The study analyzes which people have Labyrinthitis with Crohn's disease. It is created by eHealthMe based on reports of 72 people who have Crohn's disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Crohn's disease?

Crohn's disease (a condition that causes inflammation of the gastrointestinal tract) is found to be associated with 1,351 drugs and 2,076 conditions by eHealthMe. Check the latest studies of Crohn's disease.

What is Labyrinthitis?

Labyrinthitis (inflammation of the labyrinth or inner ear) is found to be associated with 412 drugs and 1,021 conditions by eHealthMe. Check the latest studies of Labyrinthitis.



On Aug, 12, 2026

72 people who have Crohn'S Disease and Labyrinthitis are studied.

Would you have Labyrinthitis when you have Crohn's disease?

Gender of people who have Crohn'S Disease and experienced Labyrinthitis *:

  • female: 66.07 %
  • male: 33.93 %

Age of people who have Crohn'S Disease and experienced Labyrinthitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 4.44 %
  • 20-29: 17.78 %
  • 30-39: 17.78 %
  • 40-49: 20.0 %
  • 50-59: 20.0 %
  • 60+: 20.0 %

Common co-existing conditions for these people *:

  1. Pain: 8 people, 11.11%
  2. Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 5.56%
  3. Indigestion: 4 people, 5.56%
  4. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 4.17%
  5. Back Pain: 2 people, 2.78%
  6. Osteoporosis (bones weak and more likely to break): 2 people, 2.78%
  7. Migraine (headache): 2 people, 2.78%
  8. Vitamin B12 Deficiency: 1 person, 1.39%
  9. High Blood Cholesterol: 1 person, 1.39%
  10. Bone Disorder: 1 person, 1.39%

Common drugs taken by these people *:

  1. Remicade: 20 people, 27.78%
  2. Humira: 19 people, 26.39%
  3. Inflectra: 17 people, 23.61%
  4. Prednisone: 9 people, 12.50%
  5. Pentasa: 7 people, 9.72%
  6. Codeine: 6 people, 8.33%
  7. Vitamin A: 5 people, 6.94%
  8. Hydrochlorothiazide: 5 people, 6.94%
  9. Vitamin C: 5 people, 6.94%
  10. Sulfatrim: 5 people, 6.94%

Common symptoms for these people *:

  1. Dizziness: 24 people, 33.33%
  2. Nausea (feeling of having an urge to vomit): 24 people, 33.33%
  3. Diarrhea: 22 people, 30.56%
  4. Sinusitis (inflammation of sinus): 21 people, 29.17%
  5. Fatigue (feeling of tiredness): 19 people, 26.39%
  6. Cough: 18 people, 25.00%
  7. Malaise (a feeling of general discomfort or uneasiness): 17 people, 23.61%
  8. Joint Pain: 16 people, 22.22%
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 16 people, 22.22%
  10. Weight Increased: 15 people, 20.83%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Labyrinthitis?

- Check whether Labyrinthitis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Labyrinthitis:

All the conditions that are associated with Labyrinthitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Labyrinthitis and Crohn's disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: